Insulin by Jet-injection for Hyperglycemia in Diabetes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of this study is to compare the pharmacokinetic and pharmacodynamic profile of the rapid-acting insulin analogue aspart (Novorapid®) injected subcutaneously by jet-injection to that of the same insulin injected with a conventional pen in the management of hyperglycemia in subjects with diabetes
Epistemonikos ID: 7ace2ac486d5ca610b96735aa3bc4ba8d8b1db57
First added on: May 11, 2024